Financial Data and Key Metrics Changes - In Q4, the company achieved $63.4 million in total revenue, reflecting a 17% year-over-year growth, with gross margin reaching a record 73.3% [20][21] - For the full year, total revenue grew 17% to $239 million, and gross margin expanded to 72.7%, up 80 basis points from the previous year [30] - Operating income for Q4 was $2.3 million, representing an operating margin of 3.6%, an improvement of 30 basis points year-over-year [23] Business Line Data and Key Metrics Changes - Weave Payments grew at more than twice the rate of total revenue in 2025, driven by new capabilities like automated payment reminders and bulk collections [16] - The specialty medical vertical became the second-largest by location count, with significant growth in Q4, adding more locations than any previous quarter [16] Market Data and Key Metrics Changes - The company has expanded its estimated total addressable market (TAM) by approximately $7 billion to an estimated $22 billion following the acquisition of TrueLark [19] - The dental market remains a key focus, with Weave being endorsed by the American Dental Association, providing access to 160,000 members [20] Company Strategy and Development Direction - The company aims to enhance patient experiences through a unified platform that reduces administrative burdens for healthcare professionals [5][6] - Weave is focusing on AI-powered solutions to automate workflows, thereby improving operational efficiency and customer retention [9][10] - The acquisition of TrueLark is seen as a foundational step in enhancing AI receptionist capabilities, addressing staffing challenges in practices [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of revenue growth and margin expansion, highlighting the importance of ongoing investments in innovation [17][30] - The company anticipates strong growth in specialty medical and mid-market sectors, with expectations for continued momentum in 2026 [31][32] Other Important Information - The company ended Q4 with $81.7 million in cash and short-term investments, reflecting strong liquidity [23] - Free cash flow for the full year was $12.9 million, representing a 24% year-over-year growth [24] Q&A Session Summary Question: Can you elaborate on the CareCredit integration? - The CareCredit partnership opens avenues for capturing volumes that would otherwise flow through CareCredit, enhancing payment solutions for customers [35][36] Question: What are the growth expectations across different subverticals for 2026? - Management anticipates strong growth across specialty medical and mid-market sectors, with specialty medical expected to lead due to recent marketing efforts and integrations [37][38] Question: How do you plan to monetize the new AI capabilities? - The company is exploring whether to price new functionalities as additional modules or include them in existing bundles, confident in the ability to monetize the value delivered [42][43] Question: Have churn rates stabilized in older specialty medical cohorts? - Churn rates have shown improvement, returning to historical levels, with ongoing integrations contributing to this stabilization [44][45] Question: What are the investment and hiring priorities for the coming year? - The company prioritizes investments in product and engineering, particularly in AI and telephony, alongside adjustments in the go-to-market strategy for efficiency [52][54] Question: How does Weave differentiate its AI capabilities from competitors? - Weave's unique advantages include ownership of the telephony stack, deep industry-specific workflows, and the ability to retain context across interactions, setting it apart from competitors [56][58]

Akamai Technologies (NasdaqGS:AKAM) Q4 2025 Earnings call February 19, 2026 04:30 PM ET Company ParticipantsAidan Daniels - Equity Research AssociateArti Vula - Equity Research AssociateEd McGowan - CFOFatima Boolani - Co-Head of US Software Equity Research and Managing DirectorMark Stoutenberg - Head of Investor RelationsRishi Jaluria - Managing Director of Software Equity ResearchRoger Boyd - Executive DirectorSanjit Singh - Executive DirectorTom Leighton - CEOVijay Homan - Equity Research AssociateConfer ...

Core Insights - Kneat.com, Inc. has signed a Master Services Agreement with a U.S.-based global pharmaceutical packaging and drug-delivery manufacturer, marking a significant partnership in the digital validation and quality process automation sector [1][2] Company Overview - Kneat Solutions specializes in providing digital validation and compliance solutions for highly regulated industries, with its platform Kneat Gx recognized for its efficiency and user-friendly design [6] - The company is fully ISO 9001 and ISO 27001 certified, and its platform is compliant with 21 CFR Part 11/Annex 11, ensuring high standards of regulatory compliance [6] Customer and Market Impact - The new customer operates over 45 manufacturing facilities globally, employing more than 13,000 people across various regions, including the U.S., Europe, Asia, and South America [2] - The initial deployment of Kneat Gx will focus on Commissioning, Qualification, and Validation (CQV) at the customer's lead site, with plans for expansion to all GMP-regulated sites [2] Product Features and Benefits - Kneat's platform is noted for its robust data integrity capabilities, ensuring compliance actions and documented outcomes are fully attributable, traceable, and audit-ready [3] - The platform is designed to support the highest standards of data integrity and compliance, which is increasingly important as life sciences companies modernize their quality systems [4] - Kneat Gx has been shown to reduce man-hours associated with validation documentation by up to 50% and accelerate review and approval cycles by up to 50% [6]

All forward-looking statements are made as of February 19, 2026, and reflect our current expectations only. We undertake no obligation to update or revise these statements to conform to actual results or revised expectations, except as required by law. By reviewing this presentation, you acknowledge that you will be solely responsible for your own assessment of the market and our market position and that you will conduct your own analysis and be solely responsible for forming your own view of the potential ...

Contact: Cameron Janke VP Finance Domo [IR@domo.com]Social Media Profiles[Domo on Facebook][Domo on LinkedIn][Domo on X]More News From Domo, Inc.Get RSS Feed## Domo Launches Domo MMM, an AI- Powered Marketing Measurement Service Built for Real Budget AccountabilitySILICON SLOPES, Utah-- ([BUSINESS WIRE])--Domo (Nasdaq: DOMO) today announced the launch of Domo MMM, a new AI- sidekick for marketers that powers measurement and is designed to help organizations understand which marketing investments are truly d ...

Industry Overview - Software stocks have been underperforming for several months, raising concerns about the impact of artificial intelligence on traditional software-as-a-service business models [1] - The introduction of AI technology is significantly altering the landscape of code writing, which may disrupt established software companies [1] Company Insights - Even well-established companies in the software sector have experienced substantial declines in stock performance due to these market shifts [1]

Achieved 6.2% organic revenue growth in 2025 by aligning services with global megatrends including the energy transition, digitalization, and sustainability requirements. Expanded adjusted EBITDA margins by 300 basis points to 25.9%, significantly exceeding long-term targets through improved laboratory utilization and technology-enabled employee productivity. Navigated geopolitical uncertainties and trade policy shifts by leveraging a diversified global footprint and the essential nature of safety cer ...

This presentation is proprietary and is intended solely for the information of the persons to whom it is presented. Disclosure of this presentation, its contents, extracts or abstracts to third parties is not authorized without the express written permission of Five9, Inc. (the "Company"), and it may not be retained, reproduced or distributed, in whole or in part, by any means (including electronic) without the prior written consent of Five9, Inc. This presentation speaks only as of the date of first public ...

Weave Overview Q4 2025 NYSE : WEAV FEBRUARY 2026 1 Safe Harbor Statement This presentation has been prepared by Weave Communications, Inc. ("Weave", "we", "us", or "our") for informational purposes only and not for any other purpose. This presentation contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995 that are based on our management's current expectations and projections about future events and financial trends that we believe may affect our financial conditio ...

Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions [Accessibility Statement] Skip NavigationSUNNYVALE, Calif., Feb. 19, 2026 /PRNewswire/ -- [Synopsys], Inc. (NASDAQ: SNPS) today announced the appointment of Peter A. Shimer to its board of directors. Shimer brings four decades of experience at international public accounting firm Deloitte where he held numerous executive roles, including serving as its interim chief executive officer (CEO). During ...